← All trials
NCT06237413
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 10, 2023
- Primary completion
- Feb 28, 2026
- Completion date
- Feb 28, 2026
- First posted
- Feb 1, 2024
- Last posted
- Mar 6, 2024
- Enrollment
- 110
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Suzhou Zelgen Biopharmaceuticals Co.,LtdLead sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,LtdOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.